Scientists identify microRNA as possible cause of chemotherapy resistance

Scientists may have uncovered a mechanism for resistance to paclitaxel in ovarian cancer, microRNA-31, suggesting a possible therapeutic target for overcoming chemotherapy resistance.

Mohamed K. Hassan, Ph.D., a postdoctoral fellow at Hokkaido University in Japan, completed the research as a collaborative study with his colleagues when he was a professional assistant in South Valley University in Egypt. Results of this study were presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.

"MicroRNAs do not code protein, but they regulate other proteins' expression," said Hassan. "So identifying any as responsible for chemoresistance is, in fact, introducing a real reason for the mechanism."

Ovarian cancer is typically responsive to chemotherapy with , but sometimes cancer cell lines become resistant, which renders useless. Hassan's research team analyzed a set of microRNAs and identified microRNA-31 as being responsible for this chemoresistance. MicroRNA-31 regulates the protein IFITM-1.

"We need to further verify this observation in clinical samples and find a way to inhibit this target protein to improve the effect of paclitaxel and prevent the risk of recurrence," he said.


Explore further

Extracellular protein sensitizes ovarian cancer cells to chemotherapy

Citation: Scientists identify microRNA as possible cause of chemotherapy resistance (2010, March 11) retrieved 7 December 2019 from https://medicalxpress.com/news/2010-03-scientists-microrna-chemotherapy-resistance.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments